Terms: = Lung cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
23 results:
1. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan.
Kito S; Suda Y; Tanabe S; Takizawa T; Nagahata T; Tohyama N; Okamoto H; Kodama T; Fujita Y; Miyashita H; Shinoda K; Kurooka M; Shimizu H; Ohno T; Sakamoto M
J Radiat Res; 2024 Mar; 65(2):159-167. PubMed ID: 38151953
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.
Pak S; Jung KW; Park EH; Ko YH; Won YJ; Joung JY
Investig Clin Urol; 2022 Mar; 63(2):175-183. PubMed ID: 35244991
[TBL] [Abstract] [Full Text] [Related]
4. MiR-519d-3p enhances the sensitivity of non-small-cell lung cancer to tyrosine kinase inhibitors.
Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
Mamm Genome; 2021 Dec; 32(6):508-516. PubMed ID: 34586488
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of the Long Noncoding RNA HIF2PUT Inhibits Non-Small Cell lung cancer Cell Proliferation and Invasion Through HIF-2a Pathway.
Wang J; Tian Y; Yu M; Ma M; Gao Y
Cancer Biother Radiopharm; 2023 Jun; 38(5):275-281. PubMed ID: 34287062
[No Abstract] [Full Text] [Related]
6. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
Wang D; Fu B; Peng Z; Yang D; Han M; Li M; Yang Y; Yang T; Sun L; Li W; Shi W; Yao X; Ma Y; Xu F; Wang X; Chen J; Xia D; Sun Y; Dong L; Wang J; Zhu X; Zhang M; Zhou Y; Pan A; Hu X; Mei X; Wei H; Xu X
Front Med; 2021 Jun; 15(3):486-494. PubMed ID: 33687643
[TBL] [Abstract] [Full Text] [Related]
7. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of epas1.
Yu S; Li Y; Ren H; Zhou H; Ning Q; Chen X; Hu T; Yang L
Cancer Chemother Pharmacol; 2021 Feb; 87(2):207-215. PubMed ID: 33221963
[TBL] [Abstract] [Full Text] [Related]
8. epas1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition.
Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
Strahlenther Onkol; 2021 Feb; 197(2):141-149. PubMed ID: 32681351
[TBL] [Abstract] [Full Text] [Related]
9. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
Krushkal J; Silvers T; Reinhold WC; Sonkin D; Vural S; Connelly J; Varma S; Meltzer PS; Kunkel M; Rapisarda A; Evans D; Pommier Y; Teicher BA
Clin Epigenetics; 2020 Jun; 12(1):93. PubMed ID: 32586373
[TBL] [Abstract] [Full Text] [Related]
10. Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer.
Zhou H; Sun Y; Xiu W; Han J; Zhong L; Suo J; Wei H; Wang Y; Zhu J
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2979-2988. PubMed ID: 32518972
[TBL] [Abstract] [Full Text] [Related]
11. Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates.
De Bastiani MA; Klamt F
Cancer Med; 2019 Nov; 8(15):6717-6729. PubMed ID: 31503425
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.
Ma H; Liu B; Wang S; Liu J
Cell Biochem Funct; 2016 Dec; 34(8):613-619. PubMed ID: 27862077
[TBL] [Abstract] [Full Text] [Related]
14. Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis.
Yang Q; Wang P; Cui J; Wang W; Chen Y; Zhang T
J Ethnopharmacol; 2016 Dec; 193():255-265. PubMed ID: 27566197
[TBL] [Abstract] [Full Text] [Related]
15. Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.
Sanders H; Qu K; Li H; Ma L; Barlan C; Zhang X; Prentice J; Wolfson D; Crossley B; Sferruzza A; Sninsky J; Ross D; Grupe A; Catanese J; Hantash F; Waldman F
Mol Diagn Ther; 2016 Jun; 20(3):241-53. PubMed ID: 27084556
[TBL] [Abstract] [Full Text] [Related]
16. [Efficacy for artery chemoembolization combined with radiofrequency ablation in the treatment of advanced non-small cell lung cancer].
Yang XG; Wu G; Li ZW; Wu H; Sun YY; Wen HH; Xu GH
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):539-43. PubMed ID: 26902194
[TBL] [Abstract] [Full Text] [Related]
17. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract] [Full Text] [Related]
18. Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.
Zhen Q; Liu JF; Liu JB; Wang RF; Chu WW; Zhang YX; Tan GL; Zhao XJ; Lv BL
Cancer Biol Ther; 2015; 16(4):549-57. PubMed ID: 25831463
[TBL] [Abstract] [Full Text] [Related]
19. Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.
de Haas S; Delmar P; Bansal AT; Moisse M; Miles DW; Leighl N; Escudier B; Van Cutsem E; Carmeliet P; Scherer SJ; Pallaud C; Lambrechts D
Angiogenesis; 2014 Oct; 17(4):909-20. PubMed ID: 25012543
[TBL] [Abstract] [Full Text] [Related]
20. Lower blood calcium associates with unfavorable prognosis and predicts for bone metastasis in NSCLC.
Shen H; Li Y; Liao Y; Zhang T; Liu Q; Du J
PLoS One; 2012; 7(3):e34264. PubMed ID: 22479582
[TBL] [Abstract] [Full Text] [Related]
[Next]
